A Randomized, Multicenter Open Label Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis.

Trial Profile

A Randomized, Multicenter Open Label Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2017

At a glance

  • Drugs Ciclosporin (Primary) ; Ciclosporin (Primary) ; Infliximab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms CYSIF
  • Most Recent Events

    • 04 Jan 2017 Results assessing long term outcomes from patients with steroid-refractory acute severe ulcerative-colitis published in the Gut.
    • 10 Oct 2012 Results published in the Lancet.
    • 10 Oct 2012 Primary endpoint 'Treatment-failure-rate' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top